Roles of 5-HT(1A) receptors in the dorsal raphe and dorsal hippocampus in anxiety assessed by the behavioral effects of 8-OH-DPAT and S 15535 in a modified Geller-Seifter conflict model

Neuropharmacology

Volumn 39, Issue 6, 2000, Pages 1037-1043

  Cervo, L ^a   Mocaer E ^b   Bertaglia, A ^a   Samanin, R ^a  

^a MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^b IRIS Institut de Recherches Internationales Servier   (France)

Author keywords

[No Author keywords available]

Indexed keywords

1 (1,4 BENZODIOXAN 5 YL) 4 (2 INDANYL)PIPERAZINE; 2 DIPROPYLAMINO 8 HYDROXYTETRALIN; N [2 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]ETHYL] N (2 PYRIDYL)CYCLOHEXANECARBOXAMIDE; SEROTONIN 1A RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANXIETY NEUROSIS; ARTICLE; CONTROLLED STUDY; DORSAL RAPHE NUCLEUS; DOSE RESPONSE; DRUG EFFECT; HIPPOCAMPUS; MALE; MODEL; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; RAT; SEROTONINERGIC SYSTEM;

8-HYDROXY-2-(DI-N-PROPYLAMINO)TETRALIN; ANIMALS; ANXIETY; CONDITIONING, OPERANT; CONFLICT (PSYCHOLOGY); HIPPOCAMPUS; MALE; PIPERAZINES; PUNISHMENT; PYRIDINES; RAPHE NUCLEI; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, SEROTONIN; RECEPTORS, SEROTONIN, 5-HT1; SEROTONIN AGONISTS; SEROTONIN ANTAGONISTS; STEREOTAXIC TECHNIQUES;

EID: 0034057583     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0028-3908(99)00189-6     Document Type: Article

References (42)

1. 1A receptors in the median raphe nucleus and dorsal hippocampus may mediate anxiolytic and anxiogenic behaviours respectively. European Journal of Pharmacology. 264:1994;259-264.
2. Barrett J.E., Vanover K.E. 5-HT receptors as targets for the development of novel anxiolytic drugs: models, mechanisms and future directions. Psychopharmacology (Berlin). 112:1993;1-12.
3. Carli M., Prontera C., Samanin R. Evidence that central 5-hydroxytryptaminergic neurones are involved in the anxiolytic activity of buspirone. British Journal of Pharmacology. 96:1989;829-836.
4. 1A receptors in the dorsal hippocampus impairs acquisition and performance of a spatial task in a water maze. Brain Research. 595:1992;50-56.
5. 1A receptors causes amnesia and anxiolytic-like but not antidepressant-like effects in the rat. European Journal of Pharmacology. 234:1993;215-221.
6. 1A receptors in the hippocampus. Behavioural and Brain Research. 67:1995;67-74.
7. 1A receptor agonist. Psychopharmacology (Berlin). 94:1988;84-91.
8. 1A receptors mediate the effects of ipsapirone on punished responding in rats. European Journal of Pharmacology. 284:1995;249-255.
9. 3) receptor antagonists increase rates of punished responding in rats. Pharmacology and Biochemistry Behavior. 52:1995;671-676.
10. 1A agonist 8-OH-DPAT on food intake in food deprived rats. Neuroreport. 3:1992;1019-1022.
11. Eison A.S., Eison M.S., Stanley M., Riblet L.A. Serotonergic mechanisms in the behavioural effect of buspirone and gepirone. Pharmacology and Biochemistry Behavior. 24:1986;701-707.
12. Evenden J.L., Angeby-Moller K. Effects of 8-hydroxy-2-(di-N-propylamino)tetralin (8-OH-DPAT) on locomotor activity and rearing of mice and rats. Psychopharmacology (Berlin). 102:1990;485-491.
13. 1A receptor modulation of anxiety in two ethological animal tests. Journal of Neuroscience. 16:1996;4810-4815.
14. 1A receptors. European Journal of Pharmacology. 237:1993;283-291.
15. Griebel G. 5-Hydroxytryptamine-interacting drugs in animal models of anxiety disorders: more than 30 years of research. Pharmacology and Therapeutics. 65:1995;319-395.
16. Handley S.L. 5-Hydroxytryptamine pathways in anxiety and its treatment. Pharmacology and Therapeutics. 66:1995;103-148.
17. 1-like and GABA receptors in the dorsal raphe nucleus of the rat. Neuropharmacology. 27:1988;993-1001.
18. 1A receptor agonist in two models of anxiety after dorsal raphe injection. Psychopharmacology (Berlin). 106:1992;261-267.
19. Hillegaart V. Effects of local application of 5-HT and 8-OH-DPAT into the dorsal and median raphe nuclei on motor activity in the rats. Physiology and Behavior. 48:1990;143-148.
20. Hodges H., Green S., Glenn B. Evidence that the amygdala is involved in benzodiazepine and serotoninergic effects on punished responding but not on discrimination. Psychopharmacology (Berlin). 92:1987;491-504.
21. Hogg S., Andrews N., File S.E. Contrasting behavioural effects of 8-OH-DPAT in the dorsal raphe nucleus and ventral hippocampus. Neuropharmacology. 33:1994;343-348.
22. Hoyer D., Boddeke H.W.G.M. Partial agonists, full agonists, antagonists: dilemmas of definition. Trends in Pharmacological Science. 14:1993;270-275.
23. Invernizzi R., Carli M., Di Clemente A., Samanin R. Administration of 8-Hydroxy-2-(di-N-propylamino)tetralin in raphe nuclei dorsalis and medianus reduces serotonin synthesis in the rat brain: differences in potency and regional sensitivity. Journal of Neurochemistry. 56:1991;243-247.
24. 1A receptor agonists and in their inhibitory effect on the firing of serotonergic neurons in the rat? Journal of Pharmacology and Experimental Therapeutics. 272:1995;920-929.
25. Kahn R.S., van Praag H.M., Wetzler S., Asnis G.M., Barr G. Serotonin and anxiety revisited. Biological Psychiatry. 23:1988;189-208.
26. 1A agonistic anxiolytic. Neuropharmacology. 30:1991;475-480.
27. 1A receptor ligands in a modified Geller-Seifter conflict model in the rat. European Journal of Pharmacology. 325:1997;121-128.
28. Kostowski W., Plaznik A., Stefanski R. Intra-hippocampal buspirone in animal models of anxiety. European Journal of Pharmacology. 168:1989;393-396.
29. 1A autoreceptors of the dorsal and median raphe nuclei. Journal of Pharmacology and Experimental Therapeutics. 269:1994;1268-1279.
30. Millan M.J., Rivet J.-M., Canton H., Lejeune F., Gobert A., Widdowson P., Bervoets K., Brocco M., Peglion J.-L. S 15535: a highly selective benzodioxopiperazine 5-HT1A receptor ligand which acts as an agonist and an antagonist at presynaptic and postsynaptic sites respectively. European Journal of Pharmacology. 230:1993;99-102.
31. Millan M.J., Hjorth S., Samanin R., Schreiber R., Jaffard R., De Ladonchamps B., Veiga S., Goument B., Peglion J.-L., Spedding M., Brocco M. S 15535, a novel benzodioxopiperazine ligand of serotonin (5-HT1A) receptors: II. Modulation of hippocampal serotonin release in relation to potential anxiolytic properties. Journal of Pharmacology and Experimental Therapeutics. 282:1997;148-161.
32. 1A agonist on locomotor and investigatory behaviors in rats differ from those of hallucinogens. Psychopharmacology (Berlin). 98:1989;321-329.
33. Nelson D.L., Herbert A., Bourgoin S., Glowinski J., Hamon H. Characteristics of central 5-HT receptors and their adaptive changes following intracerebral 5,7-dihydroxytryptamine administration in the rat. Molecular Pharmacology. 14:1978;983-995.
34. Paxinos G., Watson C. The Rat Brain in Stereotaxic Coordinates. 1986;Academic Press, Sydney.
35. Pollard G.R., Howard J.L. Effects of drugs on punished behavior: Preclinical test for anxiolytics. Pharmacology and Therapeutics. 45:1990;403-424.
36. 1A receptors in the anticonflict effect of ipsapirone. Neuropharmacology. 33:1994;1109-1115.
37. 1A receptors are critically involved in the anxiolytic effects of 8-OH-DPAT. Psychopharmacology (Berlin). 125:1996;89-91.
38. 1A receptor partial agonist, increases rates of punished responding in rats: comparison with chlordiazepoxide, ipsapirone and WAY-100635. Society for Neuroscience. 22:1996;607. (abstract).
39. 1A receptor agonist 8-OH-DPAT, ipsapirone and buspirone in the rat. European Journal of Pharmacology. 249:1993;341-351.
40. Tye N.C., Everitt B.J., Iversen S.D. 5-Hydroxytryptamine and punishment. Nature. 268:1977;741-743.
41. 1A receptor agonist 8-OH-DPAT on spatial short-term working memory in rats. Behavior and Brain Research. 1997:1984;247-258.
42. Zelman F.P., Kow L.M., Pfaff D.W. Spinal serotonin (5-HT) receptor subtypes and nociception. Journal of Pharmacology and Experimental Therapeutics. 226:1983;477-485.